Literature DB >> 23426124

EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma.

Akeesha A Shah1, Robin D LeGallo, Annemieke van Zante, Henry F Frierson, Stacey E Mills, Kenneth W Berean, Mark J Mentrikoski, Edward B Stelow.   

Abstract

The Ewing sarcoma breakpoint region 1 (EWSR1) is translocated in many sarcomas. Recently, its rearrangement has been described in salivary gland hyalinizing clear cell carcinomas (HCCCs) and in a subset of soft tissue myoepitheliomas. This study examines the presence of the EWSR1 rearrangement in a variety of salivary gland lesions including classic myoepitheliomas and HCCCs. Using a tissue microarray and whole-mount sections, fluorescence in situ hybridization (FISH) was performed on a variety of salivary gland lesions including HCCCs. The EWSR1 rearrangement was detected in 87% of HCCCs (13 of 15); all other salivary gland lesions including classic myoepitheliomas had intact EWSR1. Patients with HCCCs with rearranged EWSR1 included 1 man, 10 women, and 2 of unknown sex. Ages ranged from 35 to 83 years; the tumor size ranged from 0.8 to 5.5 cm, and the involved locations included: palate (2), base of the tongue (2), mandible (2), submandibular gland (2), lip (1), floor of the mouth (1), sublingual gland (1), inner cheek (1), and nasopharynx (1). All HCCCs were composed of sheets and nests of monotonous cells with clear cytoplasm within a hyalinized stroma. All tested cases were immunoreactive with antibodies to p63 and were nonreactive with antibodies to more conventional myoepithelial antigens (e.g., smooth muscle actin and S100 protein). These findings show that the EWSR1 rearrangement is almost a defining feature of HCCCs and also confirm that classic salivary gland myoepitheliomas are distinct from these tumors and do not share a pathogenetic relationship with their soft tissue counterparts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426124     DOI: 10.1097/PAS.0b013e3182772a15

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  18 in total

Review 1.  Myoepithelial Cells (MEC) of the Salivary Glands in Health and Tumours.

Authors:  Ravi Teja Chitturi; V Veeravarmal; R Madhavan Nirmal; B Venkat Ramana Reddy
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Hyalinizing clear cell carcinoma with EWSR1-ATF1 fusion gene: report of three cases with molecular analyses.

Authors:  Takafumi Nakano; Hidetaka Yamamoto; Toshimitsu Nishijima; Sadafumi Tamiya; Hideki Shiratsuchi; Torahiko Nakashima; Shizuo Komune; Yoshinao Oda
Journal:  Virchows Arch       Date:  2014-10-31       Impact factor: 4.064

3.  Hyalinizing Clear Cell Carcinoma of the Bronchus.

Authors:  Maryam Shahi; Michelle Dolan; Paari Murugan
Journal:  Head Neck Pathol       Date:  2017-05-16

4.  Primary Clear Cell Carcinoma of Nasopharynx-a Rare Entity.

Authors:  Rachna Goyal; Nadeem Tanveer
Journal:  Indian J Surg Oncol       Date:  2019-10-28

Review 5.  [Updates on tumours of the salivary glands : 2017 WHO classification].

Authors:  S Ihrler; O Guntinas-Lichius; C Haas; M Mollenhauer
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

Review 6.  Clinical Utility of In Situ Hybridization Assays in Head and Neck Neoplasms.

Authors:  Peter P Luk; Christina I Selinger; Wendy A Cooper; Annabelle Mahar; Carsten E Palme; Sandra A O'Toole; Jonathan R Clark; Ruta Gupta
Journal:  Head Neck Pathol       Date:  2018-11-22

Review 7.  Hyalinizing clear cell carcinoma of salivary gland: a review and update.

Authors:  Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2013-07-03

Review 8.  Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic features.

Authors:  Vickie Y Jo; Christopher D M Fletcher
Journal:  Head Neck Pathol       Date:  2015-03-25

Review 9.  What the EWSR1-ATF1 fusion has taught us about hyalinizing clear cell carcinoma.

Authors:  Jeff Tanguay; Ilan Weinreb
Journal:  Head Neck Pathol       Date:  2013-03-05

10.  Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma.

Authors:  Akeesha A Shah; Bruce M Wenig; Robin D LeGallo; Stacey E Mills; Edward B Stelow
Journal:  Head Neck Pathol       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.